US Patent Issued to Cadence Neuroscience, Mayo Foundation for Medical Education and Research on Nov. 4 for "Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods" (Washington, Minnesota, Montana Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,808, issued on Nov. 4, was assigned to Cadence Neuroscience Inc. (Redmond, Wash.) and Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods" was invented by Kent Leyde (Redmond, Wash.), Brian Lundstrom (Redmond, Wash.), Gregory Worrell (Rochester, Minn.), Squire Matthew Stead (Bozeman, Mont.) and Warren Douglas Sheffield (Redmond, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods, are discl...